MindImmune

MindImmune is a Rhode Island-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of brain diseases.

Business Model:

Revenue: $2M

Employees: 11-50

Detailed MindImmune Information

Geographic Data

MindImmune headquarters map

Address: 130 Flagg Road

City: Kingston

State: RI

Zip: 02881

Country: US

Financial Info

Stage:

series a

Raised Last:

$0

Raised Total:

$1M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

MindImmune is a Rhode Island-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of brain diseases.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
6/2022 Series A $12.4M Dolby Family Ventures
RightHill Ventures
Alzheimer’s Drug Discovery Foundation
10/2019 Seed Round $750k
8/2017 Venture Round $250k The Slater Technology Fund
1/2022 Series A 1 - Trend Investment Group
Trend Investment Group
7/2016 Seed Round 1 $500k Slater Technology Fund
Slater Technology Fund
1/2022 Series A 1 - Trend Investment Group
Trend Investment Group
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research